"findings emphasize the power of genetic modifiers PLS3 and CORO1C to unravel the cellular pathomechanisms underlying spinal muscular atrophy (SMA)--and the power of combinatorial therapy based on splice correction of SMN2 and endocytosis improvement to efficiently treat SMA"xsd:string